SBRA vs. PCH, EPR, NHI, MPW, RYN, DRH, PEB, CXW, RLJ, and LTC
Should you be buying Sabra Health Care REIT stock or one of its competitors? The main competitors of Sabra Health Care REIT include PotlatchDeltic (PCH), EPR Properties (EPR), National Health Investors (NHI), Medical Properties Trust (MPW), Rayonier (RYN), DiamondRock Hospitality (DRH), Pebblebrook Hotel Trust (PEB), CoreCivic (CXW), RLJ Lodging Trust (RLJ), and LTC Properties (LTC). These companies are all part of the "specialized reits" industry.
PotlatchDeltic (NASDAQ:PCH) and Sabra Health Care REIT (NASDAQ:SBRA) are both mid-cap construction companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, community ranking, dividends and earnings.
In the previous week, Sabra Health Care REIT had 7 more articles in the media than PotlatchDeltic. MarketBeat recorded 10 mentions for Sabra Health Care REIT and 3 mentions for PotlatchDeltic. Sabra Health Care REIT's average media sentiment score of 1.55 beat PotlatchDeltic's score of 1.15 indicating that PotlatchDeltic is being referred to more favorably in the media.
Sabra Health Care REIT received 220 more outperform votes than PotlatchDeltic when rated by MarketBeat users. Likewise, 59.95% of users gave Sabra Health Care REIT an outperform vote while only 53.13% of users gave PotlatchDeltic an outperform vote.
PotlatchDeltic has higher revenue and earnings than Sabra Health Care REIT. Sabra Health Care REIT is trading at a lower price-to-earnings ratio than PotlatchDeltic, indicating that it is currently the more affordable of the two stocks.
PotlatchDeltic has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Sabra Health Care REIT has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500.
86.1% of PotlatchDeltic shares are owned by institutional investors. Comparatively, 99.4% of Sabra Health Care REIT shares are owned by institutional investors. 2.0% of PotlatchDeltic shares are owned by company insiders. Comparatively, 1.0% of Sabra Health Care REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Sabra Health Care REIT has a net margin of 7.58% compared to Sabra Health Care REIT's net margin of 4.58%. PotlatchDeltic's return on equity of 1.74% beat Sabra Health Care REIT's return on equity.
PotlatchDeltic currently has a consensus price target of $50.67, suggesting a potential upside of 15.60%. Sabra Health Care REIT has a consensus price target of $15.71, suggesting a potential upside of 9.62%. Given Sabra Health Care REIT's higher possible upside, equities analysts clearly believe PotlatchDeltic is more favorable than Sabra Health Care REIT.
PotlatchDeltic pays an annual dividend of $1.80 per share and has a dividend yield of 4.1%. Sabra Health Care REIT pays an annual dividend of $1.20 per share and has a dividend yield of 8.4%. PotlatchDeltic pays out 315.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sabra Health Care REIT pays out 600.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. PotlatchDeltic has increased its dividend for 1 consecutive years and Sabra Health Care REIT has increased its dividend for 2 consecutive years. Sabra Health Care REIT is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Summary
Sabra Health Care REIT beats PotlatchDeltic on 12 of the 21 factors compared between the two stocks.
Get Sabra Health Care REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SBRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sabra Health Care REIT Competitors List
Related Companies and Tools
